1. Home
  2. APO vs EW Comparison

APO vs EW Comparison

Compare APO & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Global Management Inc. (New)

APO

Apollo Global Management Inc. (New)

N/A

Current Price

$111.18

Market Cap

70.8B

Sector

Finance

ML Signal

N/A

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

N/A

Current Price

$101.85

Market Cap

61.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
APO
EW
Founded
1990
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.8B
61.6B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
APO
EW
Price
$111.18
$101.85
Analyst Decision
Buy
Buy
Analyst Count
23
30
Target Price
★ $146.76
$113.83
AVG Volume (30 Days)
3.4M
★ 4.4M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 1.94%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.61
Revenue
★ $32,049,000,000.00
$6,067,600,000.00
Revenue This Year
N/A
$12.24
Revenue Next Year
$16.57
$9.84
P/E Ratio
★ N/A
$64.53
Revenue Growth
★ 22.73
11.55
52 Week Low
$99.56
$74.66
52 Week High
$153.29
$108.00

Technical Indicators

Market Signals
Indicator
APO
EW
Relative Strength Index (RSI) 39.91 60.54
Support Level $101.77 $82.21
Resistance Level $114.70 N/A
Average True Range (ATR) 4.63 2.98
MACD -0.55 -0.16
Stochastic Oscillator 6.32 61.41

Price Performance

Historical Comparison
APO
EW

About APO Apollo Global Management Inc. (New)

Apollo is one of the world's largest alternative asset managers, with $1.047 trillion in total assets under management, or AUM, including $858.0 billion in fee-earning assets, at the end of June 2026. The company has two core operating segments: asset management and retirement services. Apollo operates with scale in most of its major asset management endeavors—private equity (with an estimated $137.2 billion in total AUM and $76.3 billion in fee-earning AUM), real estate/real assets ($60.8 billion/$27.6 billion), and credit ($849.3 billion/$754.1 billion). Apollo has a distribution profile that is likely not too far off from the industry averages—with 84% of its assets held by institutional investors and 16% by high-net-worth clients.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: